IL128280A0 - Method fro treating bipolar disorder - Google Patents
Method fro treating bipolar disorderInfo
- Publication number
- IL128280A0 IL128280A0 IL12828097A IL12828097A IL128280A0 IL 128280 A0 IL128280 A0 IL 128280A0 IL 12828097 A IL12828097 A IL 12828097A IL 12828097 A IL12828097 A IL 12828097A IL 128280 A0 IL128280 A0 IL 128280A0
- Authority
- IL
- Israel
- Prior art keywords
- bipolar disorder
- treating bipolar
- method fro
- fro treating
- disorder
- Prior art date
Links
- 208000020925 Bipolar disease Diseases 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines Containing Plant Substances (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Processing Of Solid Wastes (AREA)
- Press Drives And Press Lines (AREA)
- Nonmetallic Welding Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2290096P | 1996-08-01 | 1996-08-01 | |
| PCT/US1997/013185 WO1998005324A1 (en) | 1996-08-01 | 1997-07-28 | Method for treating bipolar disorder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL128280A0 true IL128280A0 (en) | 1999-11-30 |
Family
ID=21812011
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12828097A IL128280A0 (en) | 1996-08-01 | 1997-07-28 | Method fro treating bipolar disorder |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0821955B1 (cs) |
| JP (1) | JP2000515547A (cs) |
| KR (1) | KR20000029647A (cs) |
| CN (1) | CN1226165A (cs) |
| AT (1) | ATE213413T1 (cs) |
| AU (1) | AU716972B2 (cs) |
| BR (1) | BR9710901A (cs) |
| CA (1) | CA2261802C (cs) |
| CZ (1) | CZ27299A3 (cs) |
| DE (1) | DE69710526T2 (cs) |
| DK (1) | DK0821955T3 (cs) |
| EA (1) | EA199900174A1 (cs) |
| ES (1) | ES2171838T3 (cs) |
| HU (1) | HUP9904578A2 (cs) |
| IL (1) | IL128280A0 (cs) |
| NO (1) | NO990436D0 (cs) |
| PL (1) | PL331407A1 (cs) |
| PT (1) | PT821955E (cs) |
| WO (1) | WO1998005324A1 (cs) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10265311B2 (en) | 2009-07-22 | 2019-04-23 | PureTech Health LLC | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation |
| PT3061821T (pt) | 2009-07-22 | 2019-09-05 | PureTech Health LLC | Composições para tratamento de distúrbios melhorados por ativação de recetores muscarínicos |
| JP6440625B2 (ja) | 2012-11-14 | 2018-12-19 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 精神分裂病を処置するための方法および組成物 |
| US10933020B2 (en) | 2018-09-28 | 2021-03-02 | Karuna Therapeutics, Inc. | Compositions and methods for treating disorders ameliorated by muscarinic receptor activation |
| CN111430027B (zh) * | 2020-03-18 | 2023-04-28 | 浙江大学 | 基于肠道微生物的双相情感障碍生物标志物及其筛选应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5043345A (en) * | 1989-02-22 | 1991-08-27 | Novo Nordisk A/S | Piperidine compounds and their preparation and use |
| US5376668A (en) * | 1990-08-21 | 1994-12-27 | Novo Nordisk A/S | Heterocyclic compounds |
| ATE218864T1 (de) * | 1993-08-19 | 2002-06-15 | Novo Nordisk As | Verwendung von piperidin-derivaten in der behandlung von schizophrenie |
| US5821371A (en) * | 1994-10-24 | 1998-10-13 | Eli Lilly And Comany | Heterocyclic compounds and their preparation and use |
| ES2144581T3 (es) * | 1994-10-31 | 2000-06-16 | Lilly Co Eli | Tetrahidropiridina oxadiazol o tiadiazol para tratar la ansiedad. |
| US5488056A (en) * | 1994-10-31 | 1996-01-30 | Eli Lilly And Company | Method for treating anxiety |
-
1997
- 1997-07-25 EP EP97305585A patent/EP0821955B1/en not_active Expired - Lifetime
- 1997-07-25 ES ES97305585T patent/ES2171838T3/es not_active Expired - Lifetime
- 1997-07-25 AT AT97305585T patent/ATE213413T1/de active
- 1997-07-25 DE DE69710526T patent/DE69710526T2/de not_active Expired - Lifetime
- 1997-07-25 DK DK97305585T patent/DK0821955T3/da active
- 1997-07-25 PT PT97305585T patent/PT821955E/pt unknown
- 1997-07-28 HU HU9904578A patent/HUP9904578A2/hu unknown
- 1997-07-28 JP JP10508002A patent/JP2000515547A/ja not_active Ceased
- 1997-07-28 WO PCT/US1997/013185 patent/WO1998005324A1/en not_active Ceased
- 1997-07-28 IL IL12828097A patent/IL128280A0/xx unknown
- 1997-07-28 BR BR9710901A patent/BR9710901A/pt not_active Application Discontinuation
- 1997-07-28 KR KR1019997000720A patent/KR20000029647A/ko not_active Withdrawn
- 1997-07-28 CZ CZ99272A patent/CZ27299A3/cs unknown
- 1997-07-28 EA EA199900174A patent/EA199900174A1/ru unknown
- 1997-07-28 AU AU40468/97A patent/AU716972B2/en not_active Ceased
- 1997-07-28 PL PL97331407A patent/PL331407A1/xx unknown
- 1997-07-28 CN CN97196820A patent/CN1226165A/zh active Pending
- 1997-07-28 CA CA002261802A patent/CA2261802C/en not_active Expired - Lifetime
-
1999
- 1999-01-29 NO NO990436A patent/NO990436D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE213413T1 (de) | 2002-03-15 |
| AU4046897A (en) | 1998-02-25 |
| BR9710901A (pt) | 1999-08-17 |
| EP0821955A3 (en) | 1998-04-22 |
| NO990436L (no) | 1999-01-29 |
| EP0821955B1 (en) | 2002-02-20 |
| DE69710526T2 (de) | 2002-10-02 |
| CZ27299A3 (cs) | 1999-08-11 |
| HUP9904578A2 (hu) | 2000-06-28 |
| PL331407A1 (en) | 1999-07-19 |
| EP0821955A2 (en) | 1998-02-04 |
| PT821955E (pt) | 2002-07-31 |
| CA2261802C (en) | 2006-11-07 |
| NO990436D0 (no) | 1999-01-29 |
| DE69710526D1 (de) | 2002-03-28 |
| JP2000515547A (ja) | 2000-11-21 |
| KR20000029647A (ko) | 2000-05-25 |
| ES2171838T3 (es) | 2002-09-16 |
| AU716972B2 (en) | 2000-03-09 |
| CN1226165A (zh) | 1999-08-18 |
| DK0821955T3 (da) | 2002-03-18 |
| EA199900174A1 (ru) | 1999-08-26 |
| CA2261802A1 (en) | 1998-02-12 |
| WO1998005324A1 (en) | 1998-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW269678B (cs) | ||
| MX9302932A (es) | Nuevas 4-aza-5&-androstan-3-onas 7b-substituidas como inhibidores de la5&-reductasa. | |
| HU9301361D0 (en) | Method for producing 4-aryl-piperazines and 4-aryl-piperidines | |
| IL106677A0 (en) | Novel 7-(substituted)-8-(substituted-9-(substituted amino)-6-demethyl-6-deoxytetracyclines | |
| IL119118A0 (en) | 9-Ú(Haloacyl) amido¾-7- (substituted)-6- demethyl-6-deoxytetracycline intermediates | |
| GB9722520D0 (en) | Compounds | |
| IL106676A0 (en) | Novel 7-(substituted)-8-(substituted-9-(substituted glycyl)amido)-6-demethyl-6-deoxytetracyclines | |
| GB9406857D0 (en) | Improvements in or relating to organic compounds | |
| HU9403311D0 (en) | NEW 7BéTA-SUBSTITUTED-4-AZA-5ALPHA-CHOLESTAN-ONES AS 5-ALPHA-REDUCTASE INHIBITORS | |
| DE69814635D1 (de) | Verfahren zur herstellung von 2-hydroxybenzamidderivaten | |
| EP0924199A4 (cs) | ||
| TW287103B (cs) | ||
| IL147575A0 (en) | Method for purifying keratinocyte growth factors | |
| IL128280A0 (en) | Method fro treating bipolar disorder | |
| ZA976854B (en) | Treatment of psychotic disorders. | |
| HUT70757A (en) | Pharmaceutical compositions for treating skin disorders | |
| PL335186A1 (en) | Method of treating an iron salts containing solution | |
| MY133014A (en) | Method for treating copd | |
| ZA958609B (en) | Method for purifying keratinocyte growth factors | |
| IL112469A0 (en) | Composition for the treatment of an epidermal disorder | |
| TW277059B (cs) | ||
| ZA983298B (en) | Methods for reducing fibrinogen. | |
| DE3678015D1 (en) | N-carboxyalcoyl-2-oxo-3-diaryl-5-6 triazine als heilmittel. | |
| DE69711506D1 (de) | Methylsulfomycin 1, Verfahren zu dessen Herstellung und Verwendung | |
| GR3036968T3 (en) | Adamantyl substituted oxindoles as pharmaceutical agents |